Disclaimer

The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Blog posts

Fluid Overload – the overlooked challenge in heart failure
Ian Crosbie – 22 October 2020

Read the post

Serving the needs of NASH patients
Ian Crosbie, 12 November 2020

Read the post

PRESS RELEASES

SUBSCRIBE TO OUR PRESS RELEASES